TGFB1 and hepatocellular carcinoma: Based on consensus clustering, we further stratified HCC patients into two immune subtypes: an immune-inflamed phenotype enriched for immune response and chemotaxis signals, and an immune-excluded phenotype characterized by immunosuppressive pathways such as Wnt/β-catenin and TGF-β.